|
PCYT1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.10009999999095E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.576980E-04 |
| Normal-vs-Stage2 |
1.551640E-02 |
| Normal-vs-Stage3 |
4.37920000000425E-05 |
| Normal-vs-Stage4 |
5.58720000043422E-07 |
| Stage1-vs-Stage2 |
4.723600E-01 |
| Stage1-vs-Stage3 |
3.133000E-01 |
| Stage1-vs-Stage4 |
3.152300E-02 |
| Stage2-vs-Stage3 |
1.901390E-01 |
| Stage2-vs-Stage4 |
3.064400E-02 |
| Stage3-vs-Stage4 |
3.216000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.13310000000333E-05 |
| Normal-vs-AfricanAmerican |
9.062500E-03 |
| Normal-vs-Asian |
3.603400E-04 |
| Caucasian-vs-AfricanAmerican |
8.830400E-01 |
| Caucasian-vs-Asian |
6.068600E-01 |
| AfricanAmerican-vs-Asian |
6.390200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87000999999354E-05 |
| Normal-vs-Female |
7.65830000000189E-05 |
| Male-vs-Female |
2.259000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.811000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.32339999994835E-06 |
| Normal-vs-Age(61-80Yrs) |
4.391300E-04 |
| Normal-vs-Age(81-100Yrs) |
7.477800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.630390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.296200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.646800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.076200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.994000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.207600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.594200E-01 |
| Classical-VS-Follicular |
5.027600E-01 |
| Classical-VS-Other |
1.511960E-01 |
| Classical-VS-Normal |
1.588560E-04 |
| Tall-VS-Follicular |
7.000600E-01 |
| Tall-VS-Other |
3.972200E-01 |
| Tall-VS-Normal |
1.243320E-03 |
| Follicular-VS-Other |
2.980000E-01 |
| Follicular-VS-Normal |
6.405700E-04 |
| Other-VS-Normal |
3.102000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.22130000000687E-05 |
| Normal-vs-N1 |
1.86991999999719E-05 |
| N0-vs-N1 |
2.575400E-01 |
|
|
